A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York



Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis

"We are excited to receive FDA clearance for the ISR indication, which expands our addressable market for Pantheris to include a high-incidence disease state for which there are few available indicated treatment options," commented Jeff Soinski, Avinger's President and CEO.

By using this website you agree to accept Medical Device News Magazine Privacy Policy